| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,270 |
10,221 |
$209K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,573 |
1,286 |
$14K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
816 |
698 |
$11K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,968 |
658 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
682 |
578 |
$7K |
| 99497 |
|
455 |
417 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
432 |
387 |
$6K |
| 99223 |
Prolong inpt eval add15 m |
338 |
271 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
210 |
186 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
264 |
230 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
419 |
189 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
43 |
41 |
$3K |
| 99442 |
|
249 |
201 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
679 |
216 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
29 |
25 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
129 |
122 |
$1K |
| 99406 |
|
277 |
204 |
$1K |
| 80305 |
|
114 |
107 |
$546.96 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
13 |
$307.86 |
| 90686 |
|
35 |
33 |
$257.25 |
| 99307 |
|
2,134 |
1,746 |
$178.99 |
| 93000 |
|
47 |
37 |
$174.32 |
| 90674 |
|
95 |
87 |
$148.10 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
480 |
431 |
$120.59 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
14 |
$118.67 |
| 82962 |
|
295 |
251 |
$103.25 |
| 90756 |
|
20 |
20 |
$45.58 |
| G0008 |
Administration of influenza virus vaccine |
119 |
111 |
$45.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27 |
24 |
$22.79 |
| 81002 |
|
26 |
25 |
$14.10 |
| 3078F |
|
3,384 |
2,847 |
$8.97 |
| 1125F |
|
3,479 |
2,920 |
$7.06 |
| 3074F |
|
2,377 |
2,021 |
$6.15 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
16 |
13 |
$3.14 |
| 1159F |
|
4,024 |
3,395 |
$3.09 |
| 1160F |
|
4,047 |
3,414 |
$3.08 |
| 1126F |
|
1,095 |
974 |
$2.56 |
| 1101F |
|
3,900 |
3,259 |
$2.35 |
| 3066F |
|
654 |
528 |
$1.04 |
| 3075F |
|
200 |
176 |
$0.63 |
| 3044F |
|
29 |
29 |
$0.14 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
36 |
35 |
$0.07 |
| 4040F |
|
38 |
36 |
$0.00 |
| G8937 |
Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given |
15 |
14 |
$0.00 |
| G8935 |
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
15 |
15 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
29 |
29 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
30 |
29 |
$0.00 |
| 3288F |
|
35 |
34 |
$0.00 |
| 3046F |
|
17 |
16 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
35 |
34 |
$0.00 |
| 1100F |
|
35 |
34 |
$0.00 |
| G9665 |
Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy |
13 |
13 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
28 |
28 |
$0.00 |
| G9509 |
Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 |
29 |
29 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
31 |
31 |
$0.00 |
| 2022F |
|
36 |
35 |
$0.00 |
| 0518F |
|
34 |
34 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
1,632 |
1,319 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
165 |
158 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
509 |
408 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
245 |
191 |
$0.00 |
| 1036F |
|
48 |
46 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
31 |
31 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
242 |
190 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
308 |
285 |
$0.00 |
| 3017F |
|
37 |
36 |
$0.00 |
| G8450 |
Beta-blocker therapy prescribed |
18 |
18 |
$0.00 |
| 3079F |
|
13 |
12 |
$0.00 |
| 93922 |
|
17 |
12 |
$0.00 |
| 3061F |
|
14 |
14 |
$0.00 |
| G8452 |
Beta-blocker therapy not prescribed |
22 |
21 |
$0.00 |